|
Up First
- HAN: Increase in invasive serogroup Y meningococcal disease in the United States
- Wyoming Immunization Conference
Wyoming Immunization Registry
- Did you know: Lot number summary report
- New quick reference guides available
- WyIR Help Desk
Training
- Red Book online webinar: Identifying measles in the pediatric setting
Resources
- New MenABCWY vaccine available
- CDC recommends suspending seasonal administration of nirsevimab (Beyfortus) for RSV immunization of infants and toddlers at the end of March in most jurisdictions
- Communication tools
| |
|
Increase in invasive serogroup Y meningococcal disease in the United States
From the Centers for Disease Control and Prevention March 28
The Centers for Disease Control and Prevention is issuing this Health Alert Network (HAN) Health Advisory to alert healthcare providers to an increase in invasive meningococcal disease … Healthcare providers should, 1) have a heightened suspicion for meningococcal disease, particularly among populations disproportionately affected by the current increase, 2) be aware that patients may present without symptoms typical of meningitis, and 3) ensure that all people recommended for meningococcal vaccination, including people with HIV, are up to date for meningococcal vaccines.
Read the full report at this link.
| |
Registration is open for the Wyoming Immunization Conference, June 25-27, in Laramie. Highlights include a meningitis survivor story, the latest clinical recommendations, Wyoming Immunization Registry training, and more. Visit our website for more information. Continuing education for this activity is pending. See the final announcement for details. | |
Wyoming Immunization Registry | |
|
Lot number summary report
John Taylor, Client Management Specialist
Wyoming Immunization Registry (WyIR) authorized users can run the Lot Number Summary report in the WyIR to summarize information about specific vaccine lot numbers.
The Lot Number Summary report displays a list of active, non-expired lots, and provides a summary of those lots. The summary includes the starting number of doses, how many have been used, transferred, wasted, and more. In addition, this report also summarizes data such as lot number, manufacturer, and expiration dates. Multiple vaccines can be selected.
To run this report in the WyIR, navigate to the Reports tab > click “Report Module” > then, under the “Vaccine” section, click the “Lot Number Summary” link. Enter the search criteria and click “Create Report.” The report is displayed in a separate browser tab and can be printed.
| |
|
New quick reference guides available
Immunization Unit staff
The Immunization Unit is updating quick reference guides to give providers a quick and easy guide for processes such as data entry and vaccine ordering. As soon as they are updated, the guides are added to the website.
The following guides are now updated and available for download on the
Training Library web page:
These presentations are available for download on the Training Library web page under “Office Hours”:
| |
WyIR Help Desk
The Wyoming Immunization Registry (WyIR) Help Desk is the first point of contact for WyIR concerns including: user access, password resets, inventory concerns, reconciliation, reports, patient merges and deduplication, forecast, and more.
The Help Desk team responds to most issues within 48 business hours. Issues that cannot be resolved by the Help Desk are escalated to the Immunization Unit via a central email, which is monitored by Immunization Unit staff.
The Help Desk can be reached at 1-833-221-1451, wyir.helpdesk@wyo.gov, or the chat feature in the bottom left corner of the WyIR home page.
For questions about the Docket application, email docket.helpdesk@wyo.gov or call 307-777-7952.
| |
|
Red Book online webinar: Identifying measles in the pediatric setting
Katie Milewski - American Academy of Pediatrics
Most pediatricians have never seen a case of measles. Given the increase in global and domestic measles outbreaks, healthcare providers should familiarize themselves with the clinical features of measles to quickly identify it and minimize the spread of the virus. In this 5-minute webinar, Dr Sean O’Leary outlines the clinical features of measles, discusses the incubation and infection periods for measles, and explains how pediatricians can assess the risk of measles in someone presenting to their office with symptoms. Watch the 5-minute video here: https://publications.aap.org/redbook/resources/15686.
| |
|
New MenABCWY vaccine available
Heidi Gurov, RN, Nurse Consultant
Pfizer’s new pentavalent meningococcal ABCWY (MenABCWY) vaccine, Penbraya, is now available for ordering through the Vaccines for Children program.
Julie Rittelsrud, CNP, PhD, from Pfizer will be presenting a webinar on Penbraya on Tuesday, May 21 at 12:15 pm MDT. Registration is required: https://us06web.zoom.us/meeting/register/tZYkduugrjguG9wGFBKUmuEkoLsHx3wEeMU8
The Advisory Committee on Immunization Practices (ACIP) recommendations for Penbraya have been published, and are found at https://www.cdc.gov/mmwr/volumes/73/wr/mm7315a4.htm
Highlights of recommendations:
- On October 25, 2023, the ACIP recommended that MenACWY-TT/MenB-FHbp may be administered to persons aged ≥10 years when both a quadrivalent meningococcal conjugate vaccine (MenACWY) and meningococcal B vaccine (MenB) are indicated at the same visit.
- When vaccinating older adolescents 16 years and older through shared clinical decision-making, one dose of Penbraya will be given, followed by one dose of Trumenba at least six months later.
Learn more about Penbraya: https://penbraya.pfizerpro.com/
| | |
CDC recommends suspending seasonal administration of nirsevimab (Beyfortus) for RSV immunization of infants and toddlers at the end of March in most jurisdictions
IZ Express, Issue 1750, April 3, 2024
The 2023 ACIP recommendation for administration of nirsevimab (Beyfortus, Sanofi) long-acting monoclonal antibody product for prevention of respiratory syncytial virus (RSV) disease in infants and toddlers specifies administering nirsevimab seasonally, beginning October 1 and ending March 31 in jurisdictions with RSV seasonality typical of the contiguous United States. Facilities in most of the United States should suspend nirsevimab use at this time and prepare to resume administration in October 2024.
Alaska and tropical climates may have RSV circulation patterns that differ from those of most of the continental United States. Locations with tropical climates include southern Florida, Hawaii, Guam, Puerto Rico, the U.S. Virgin Islands, and the U.S.-affiliated Pacific Islands. Providers in these jurisdictions should follow state, local, or territorial guidance on the timing of nirsevimab administration.
Related Links
| |
|
Communication tools
Immunization Unit staff
-
The Immunization Unit has copies of laminated 2024 ACIP Recommended Immunization Schedules available upon request. If your clinic is interested in receiving these complimentary schedules, please fill out this form https://forms.gle/weZph7dRrH1iySYD6.
-
Docket flyers can be printed for use. Click here for the link to the printable flyer. In addition, the Immunization Unit now has wallet-size handouts that can be shipped to providers who request them. To request these wallet-size handouts, please email Janice Carney at janice.carney@wyo.gov.
| |
| May | Hepatitis Awareness Month | | May 6-10 | National Nurses Week | | May 8 | National School Nurse Day | | May 13-17 | National Women’s Health Week | | |
- American Academy of Pediatrics
- The Centers for Disease Control and Prevention
- Immunize.org
- Wyoming Department of Health Immunization Unit staff
Questions or comments? Email the editor at kelly.douglas@wyo.gov.
|
| | | |